Predictive chemotherapy of advanced breast cancer directed by MTT assay in vitro

被引:61
作者
Xu, JM
Song, ST
Tang, ZM
Jiang, ZF
Liu, XQ
Zhou, L
Zhang, J
Liu, XW
机构
[1] 307 Hosp, Beijing 100039, Peoples R China
[2] Inst Radiat Med, Beijing, Peoples R China
关键词
MTT assay; in vitro chemosensitivity; prediction of clinical response;
D O I
10.1023/A:1006122912146
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
In order to investigate the predictive value of in vitro MTT assay for directing chemotherapy of breast cancer patients, from 1992 to 1995, 156 advanced breast cancer patients who had evaluable lesions were recruited for a prospective study. Of them 83 had MTT assay before chemotherapy; the 73 patients in the MTT sensitive group received chemotherapy according to the result of the MTT assay. The other 10 patients in the MTT resistant group and 73 patients in the control group were given chemotherapy according to clinicians' discretion. The response rate in the MTT sensitive group was 76.7% (56/73). There was statistically significant difference as compared with 0 (0/10) in the MTT resistant group and 43.8% (32/73) in the control group. Between in vitro and in vivo, the overall coincident rate was 79.5% [(56 + 10)/83]. In the MTT sensitive group, the response rate of the subgroups of lesions and the chemotherapy regiments tended to be higher than that in the control group. Patients in the MTT sensitive group had longer response and survival than those in the control group. However, there was no statistical difference in the median response duration and the median survival between the two groups. Further exploration of in vitro chemosensitivity testing by MTT assay for patients with advanced breast cancer is warranted.
引用
收藏
页码:77 / 85
页数:9
相关论文
共 24 条
[1]   PREDICTION OF RESPONSE TO DRUG-THERAPY OF CANCER - A REVIEW OF INVITRO ASSAYS [J].
BELLAMY, WT .
DRUGS, 1992, 44 (05) :690-708
[2]   CHEMOSENSITIVITY TESTING OF SMALL-CELL LUNG-CANCER USING THE MTT ASSAY [J].
CAMPLING, BG ;
PYM, J ;
BAKER, HM ;
COLE, SPC ;
LAM, YM .
BRITISH JOURNAL OF CANCER, 1991, 63 (01) :75-83
[3]   RAPID ADMINISTRATION OF MULTIPLE CYCLES OF HIGH-DOSE MYELOSUPPRESSIVE CHEMOTHERAPY IN PATIENTS WITH METASTATIC BREAST-CANCER [J].
CROWN, J ;
KRITZ, A ;
VAHDAT, L ;
REICH, L ;
MOORE, M ;
HAMILTON, N ;
SCHNEIDER, J ;
HARRISON, M ;
GILEWSKI, T ;
HUDIS, C ;
GULATI, S ;
NORTON, L .
JOURNAL OF CLINICAL ONCOLOGY, 1993, 11 (06) :1144-1149
[4]   High-dose chemotherapy with autologous stem cell rescue in breast cancer [J].
Dillman, RO ;
Barth, NM ;
Nayak, SK ;
DeLeon, C ;
OConnor, A ;
Morrelli, L .
BREAST CANCER RESEARCH AND TREATMENT, 1996, 37 (03) :277-289
[5]   Endocrine treatment of advanced breast cancer [J].
Dowsett, M .
ACTA ONCOLOGICA, 1996, 35 (05) :68-72
[6]   INVITRO SENSITIVITY ASSAYS IN CANCER - A REVIEW, ANALYSIS, AND PROGNOSIS [J].
HOFFMAN, RM .
JOURNAL OF CLINICAL LABORATORY ANALYSIS, 1991, 5 (02) :133-143
[7]   PREDICTION OF CHEMOTHERAPY RESPONSE IN HUMAN LEUKEMIA USING IN-VITRO CHEMOSENSITIVITY TEST [J].
HWANG, WS ;
CHEN, LM ;
HUANG, SH ;
WANG, CC ;
TSENG, MT .
LEUKEMIA RESEARCH, 1993, 17 (08) :685-688
[8]  
IAMBELLI M, 1997, BREAST CANC RES TREA, V44, P255
[9]   NONPARAMETRIC-ESTIMATION FROM INCOMPLETE OBSERVATIONS [J].
KAPLAN, EL ;
MEIER, P .
JOURNAL OF THE AMERICAN STATISTICAL ASSOCIATION, 1958, 53 (282) :457-481
[10]  
KUSUMOTO T, 1992, ONCOLOGY, V49, P343